VC Catalog · venture ecosystem research library
VC Catalog home Beta

Company

Immutrin Limited

Rocket Ship RatingBased on the data VC Catalog holds.

Rocket Ship Rating: 78 out of 100

Immutrin - Next Generation Antibody Therapy for Reversal of Amyloidosis

Also known as Immutrin Ltd

  • Biotech & therapeutics
Business model
B2B
Legal name
Immutrin Ltd
Open relationship map
Claim, correct or request removal

Record updated 29 September 2026

About

Immutrin is a biotechnology company developing next generation antibody therapy to deplete systemic amyloid deposits and reverse amyloidosis.

Loading relationship preview

Cookies on VC Catalog

We use necessary cookies to run the site (sign-in, security, remembering this choice). With your permission we also use Google Analytics to understand how the site is used. Analytics cookies are set only if you accept all cookies. Privacy policy